|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
NZ500590A
(en)
*
|
1997-04-22 |
2001-11-30 |
Cocensys Inc |
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
|
|
EP2201945B1
(en)
|
1997-11-21 |
2013-03-06 |
Purdue Neuroscience Company |
Use of substituted 2-aminoacetamides for treating or ameliorating anxiety
|
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
DE60022333T2
(de)
|
1999-04-09 |
2006-07-06 |
Euro-Celtique S.A. |
Natrium kanalblocker zusammensetzungen und deren verwendung
|
|
ATE246177T1
(de)
*
|
1999-05-28 |
2003-08-15 |
Cheil Jedang Corp |
Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
AR029489A1
(es)
|
2000-03-10 |
2003-07-02 |
Euro Celtique Sa |
Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
|
|
CZ2003686A3
(cs)
*
|
2000-08-08 |
2003-08-13 |
Ortho Mcneil Pharmaceutical, Inc. |
Neimidazolové aryloxypiperidiny
|
|
GB0025208D0
(en)
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
|
CA2427284A1
(en)
*
|
2000-10-26 |
2002-05-30 |
Tularik Inc. |
Antiinflammation agents
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
EP1392219A4
(en)
|
2001-05-10 |
2007-01-24 |
Cytovia Inc |
SUBSTITUTED N '- (ARYLCARBONYL) -BENZYLIDENE-HYDRAZIDE N' - (ARYLCARBONYL) -BENZHYDRAZIDES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS AND USE THEREOF
|
|
US6831193B2
(en)
|
2001-05-18 |
2004-12-14 |
Abbott Laboratories |
Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
|
|
ES2249589T3
(es)
*
|
2001-05-18 |
2006-04-01 |
Abbott Laboratories |
Trisustituido-n-((1s)-1,2,3,4-tetrahidro-1-naftalenil)benzamidas que inhiben receptores que contienen antagonistas p2x3 y p2x2/3.
|
|
WO2002098420A1
(en)
*
|
2001-06-01 |
2002-12-12 |
Cytovia, Inc. |
4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
|
IL160523A0
(en)
|
2001-09-03 |
2004-07-25 |
Newron Pharm Spa |
PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
|
|
AR037233A1
(es)
|
2001-09-07 |
2004-11-03 |
Euro Celtique Sa |
Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
|
|
AR036873A1
(es)
|
2001-09-07 |
2004-10-13 |
Euro Celtique Sa |
Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
|
|
AR040126A1
(es)
|
2002-05-29 |
2005-03-16 |
Glaxo Group Ltd |
Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
|
|
CA2511646A1
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
EP1438956A1
(en)
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful as antimigraine agents
|
|
EP1589959A2
(en)
*
|
2003-01-30 |
2005-11-02 |
Dynogen Pharmaceuticals Inc. |
Methods of treating lower urinary tract disorders using sodium channel modulators
|
|
EP1626718A4
(en)
*
|
2003-05-01 |
2010-05-05 |
Panacea Pharmaceuticals Inc |
METHOD FOR THE TREATMENT OF ISCHEMIC ILLNESSES
|
|
WO2006040329A1
(en)
*
|
2004-10-12 |
2006-04-20 |
Novo Nordisk A/S |
1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
CN101495116A
(zh)
|
2005-03-22 |
2009-07-29 |
哈佛大学校长及研究员协会 |
蛋白降解病症的治疗
|
|
BRPI0618051A2
(pt)
*
|
2005-11-01 |
2011-08-16 |
Transtech Pharma Inc |
uso farmacêutico de amidas substituìdas
|
|
KR20080076916A
(ko)
*
|
2005-11-01 |
2008-08-20 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
|
AU2007345292B2
(en)
|
2006-02-14 |
2013-10-31 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
AU2007214458C1
(en)
|
2006-02-14 |
2012-12-06 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase inhibitors
|
|
EP2007722A1
(en)
*
|
2006-03-21 |
2008-12-31 |
High Point Pharmaceuticals, LLC |
Adamantane derivatives for the treatment of the metabolic syndrome
|
|
KR20090014347A
(ko)
|
2006-04-07 |
2009-02-10 |
하이 포인트 파마슈티칼스, 엘엘씨 |
11β-히드록시스테로이드 탈수소효소 타입 1 활성 화합물
|
|
CA2654540C
(en)
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
EP2038255A2
(en)
*
|
2006-06-16 |
2009-03-25 |
High Point Pharmaceuticals, LLC |
Pharmaceutical use of substituted piperidine carboxamides
|
|
US8048908B2
(en)
*
|
2006-07-13 |
2011-11-01 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
EP1878721A1
(en)
*
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
WO2008101907A2
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
ZA200904916B
(en)
|
2007-02-23 |
2010-09-29 |
High Point Pharmaceuticals Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2125704A1
(en)
*
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
JP2010519239A
(ja)
*
|
2007-02-23 |
2010-06-03 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
１１−ベータ−ヒドロキシステロイドデヒドロゲナーゼの阻害因子としてのｎ−アドマンチルベンザミド
|
|
CN101652359A
(zh)
*
|
2007-03-09 |
2010-02-17 |
高点制药有限责任公司 |
作为羟类固醇脱氢酶抑制剂的吲哚-和苯并咪唑酰胺类
|
|
EP2141990A4
(en)
*
|
2007-03-28 |
2011-07-06 |
High Point Pharmaceuticals Llc |
ACTIVE COMPOUNDS ON 11BETA-HSD1
|
|
CN101677562A
(zh)
*
|
2007-04-11 |
2010-03-24 |
高点制药有限责任公司 |
新化合物
|
|
JP2010526777A
(ja)
*
|
2007-04-24 |
2010-08-05 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
置換アミドの医薬用途
|
|
EP2520561B1
(en)
|
2007-06-08 |
2016-02-10 |
MannKind Corporation |
IRE-1A Inhibitors
|
|
EP2205072B1
(en)
*
|
2007-10-15 |
2013-11-20 |
The Salk Institute for Biological Studies |
Methods for treating a variety of diseases and conditions, and compounds useful therefor
|
|
RU2515611C2
(ru)
|
2008-07-23 |
2014-05-20 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Ингибиторы деацетилазы и их применение
|
|
DE102008053242A1
(de)
|
2008-10-25 |
2010-05-06 |
Saltigo Gmbh |
Heteroaryl-Arylether
|
|
JP2012509879A
(ja)
*
|
2008-11-21 |
2012-04-26 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
アダマンチルベンズアミド化合物
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
EP2287149A1
(en)
|
2009-08-20 |
2011-02-23 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Enhancers of protein degradation
|
|
DE102010020882A1
(de)
|
2010-05-18 |
2011-11-24 |
Alzchem Trostberg Gmbh |
Semicarbazone zur Härtung von Epoxidharzen
|
|
JP2013530180A
(ja)
|
2010-06-16 |
2013-07-25 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
アリール置換インドールおよびその使用
|
|
JP2013531687A
(ja)
|
2010-07-16 |
2013-08-08 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としてのピリジン化合物
|
|
EP2616441B1
(en)
|
2010-09-17 |
2019-08-07 |
Purdue Pharma L.P. |
Pyridine compounds and the uses thereof
|
|
EP2625169B1
(en)
|
2010-10-05 |
2015-03-25 |
Purdue Pharma L.P. |
Quinazoline compounds as sodium channel blockers
|
|
PE20140421A1
(es)
|
2010-12-06 |
2014-04-26 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE PIRIMIDINONA COMO INHIBIDORES DE Lp-PLA2
|
|
CN103429571A
(zh)
|
2010-12-22 |
2013-12-04 |
普渡制药公司 |
作为钠通道阻断剂的取代吡啶
|
|
WO2013030665A1
(en)
|
2011-09-02 |
2013-03-07 |
Purdue Pharma L.P. |
Pyrimidines as sodium channel blockers
|
|
WO2013064883A1
(en)
|
2011-10-31 |
2013-05-10 |
Purdue Pharma L.P. |
Heteroaryl compounds as sodium channel blockers
|
|
AU2012321111A1
(en)
|
2011-10-31 |
2013-05-16 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
|
DE102011118501A1
(de)
|
2011-11-15 |
2013-05-16 |
Alzchem Ag |
Alkyl- oder Dialkyl-Semicarbazone als Härter für Epoxidharze
|
|
US9133131B2
(en)
|
2011-11-15 |
2015-09-15 |
Purdue Pharma L.P. |
Pyrimidine diol amides as sodium channel blockers
|
|
WO2013136170A1
(en)
|
2012-03-16 |
2013-09-19 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
|
CA2878815A1
(en)
|
2012-07-10 |
2014-01-16 |
Dana-Farber Cancer Institue, Inc. |
Anti-proliferative compounds and uses thereof
|
|
WO2014096941A1
(en)
|
2012-12-20 |
2014-06-26 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
US9120786B2
(en)
|
2013-03-04 |
2015-09-01 |
Purdue Pharma, L.P. |
Triazine carboxamides as sodium channel blockers
|
|
US9637458B2
(en)
|
2013-03-04 |
2017-05-02 |
Jeffrey Lockman |
Pyrimidine carboxamides as sodium channel blockers
|
|
CA3082427A1
(en)
|
2013-03-15 |
2014-09-25 |
Purdue Pharma L.P. |
Carboxamide derivatives and use thereof
|
|
US10253002B2
(en)
|
2013-05-01 |
2019-04-09 |
Neoculi Pty Ltd |
Compounds and methods of treating infections
|
|
WO2015031036A1
(en)
|
2013-08-26 |
2015-03-05 |
Purdue Pharma L.P. |
Azaspiro[4.5] decane derivatives and use thereof
|
|
US9359330B2
(en)
|
2013-08-26 |
2016-06-07 |
Purdue Pharma L.P. |
Substituted piperidines as sodium channel blockers
|
|
US9828348B2
(en)
|
2013-11-08 |
2017-11-28 |
Purdue Pharma L.P. |
Benzimidazole derivatives and use thereof
|
|
US9340504B2
(en)
|
2013-11-21 |
2016-05-17 |
Purdue Pharma L.P. |
Pyridine and piperidine derivatives as novel sodium channel blockers
|
|
US9745287B2
(en)
|
2013-12-20 |
2017-08-29 |
Purdue Pharma L.P. |
Pyrimidines and use thereof
|
|
US9695144B2
(en)
|
2013-12-23 |
2017-07-04 |
Purdue Pharma L.P. |
Dibenzazepine derivatives and use thereof
|
|
AU2014370407B2
(en)
|
2013-12-23 |
2018-03-29 |
Purdue Pharma L.P. |
Indazoles and use thereof
|
|
EP3089978B1
(en)
|
2013-12-30 |
2018-08-29 |
Purdue Pharma L.P. |
Pyridone-sulfone morphinan analogs as opioid receptor ligands
|
|
US10047075B2
(en)
|
2014-01-24 |
2018-08-14 |
Purdue Pharma L.P. |
Pyridines and pyrimidines and use thereof
|
|
US10738026B2
(en)
|
2014-02-12 |
2020-08-11 |
Purdue Pharma L.P. |
Isoquinoline derivatives and use thereof
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
CA2948144A1
(en)
|
2014-05-06 |
2015-11-12 |
Purdue Pharma L.P. |
Benzomorphan analogs and use thereof
|
|
EP3154972A4
(en)
|
2014-06-13 |
2017-11-22 |
Purdue Pharma L.P. |
Azamophinan derivatives and use thereof
|
|
WO2015192039A1
(en)
|
2014-06-13 |
2015-12-17 |
Purdue Pharma L.P. |
Heterocyclic morphinan derivatives and use thereof
|
|
WO2018125716A1
(en)
|
2017-01-02 |
2018-07-05 |
Purdue Pharma L.P. |
Morphinan derivatives and use thereof
|